Stay updated on Tisotumab Vedotin in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin in Cervical Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new research citation on ocular adverse events with tisotumab vedotin; no deletions observed.
    Difference
    1%
    Check dated 2025-10-12T14:33:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates a new version (v3.2.0); previous version tag v3.1.0 has been removed.
    Difference
    2%
    Check dated 2025-10-05T10:16:26.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, signaling a new release version.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:54.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:37:13.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T14:59:18.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and specific locations in Belgium, Germany, and Spain, as well as a new reference for tisotumab vedotin. The revision number has also been updated to v3.0.0.
    Difference
    3%
    Check dated 2025-08-30T11:37:21.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.